Peer-reviewed veterinary case report
Preclinical efficacy of anecortave acetate.
- Journal:
- Survey of ophthalmology
- Year:
- 2007
- Authors:
- Clark, Abbot F
- Affiliation:
- Discovery Research · United States
Abstract
Anecortave acetate is a unique ocular angiostatic cortisene that has broad-based anti-angiogenic activity in 14 different preclinical models of neovascularization, across multiple species and inducers of neovascularization. Anecortave acetate is being tested clinically for inhibition of choroidal neovascularization associated with age-related macular degeneration.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/17240256/